As published in Clinical OMICs
First Databank, Translational Software to Integrate Pharmacogenomic Data into EHRs
by Diana Kwon
First Databank (FDB), a company that provides drug and medical device knowledge to health professionals and Translational Software, a clinical decision support tools developer, recently launched a collaboration to bring pharmacogenomics drug knowledge to clinical workflows, including electronic health records (EHRs). The joint effort will combine FDB’s medicine management expertise along with Translational Software’s genomic content.
…Don Rule, the founder and CEO of Translational Software, said that in addition to the network of labs the company works with now, it could also work with organizations that want to conduct in-house testing.
“I think one of the things that is unique to the solution that we’re offering is that it allows folks to integrate genetic results from a variety of different sources,” said Chuck Tuchinda, president of FDB. “This solution will really make genetic testing results, their interpretation, and their impact in medications available to a bulk of clinicians because it can leverage results from external labs, internal labs, from anywhere they may be.”
Tuchinda added that FDB plans to provide “highly actionable data” so that when a clinician is about to prescribe a relevant drug and there is a known genetic result for that patient, the system can automatically inform them of dose or drug adjustments that are required. “One of the big differentiators of our partnership is it’s focusing on the research insights that will actually change the prescriber’s behavior,” Tuchinda noted.